Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chrysanthemic Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel ionic liquid selenium method for oxygenated compounds. Reduces waste, improves yield for pyrethroid intermediates. Reliable supplier.
Patent CN102030650B reveals high-yield synthesis for agrochemical intermediates. Achieve superior cis-trans control and reduced wastewater for supply chain efficiency.
Patent CN110467527A reveals ruthenium-catalyzed route for high-purity agrochemical intermediate with significant cost and supply chain advantages.
Novel biocatalytic resolution method for high-purity dextro-cis-chrysanthemic acid. Simplifies production, reduces costs, and ensures supply chain stability for pyrethroid manufacturers.
Efficient catalytic hydrogenolysis route for high-purity agrochemical intermediates. Reduces steps and cost for chrysanthemic acid derivatives manufacturing.
Patent CN1020451C details a novel enantioselective route for cis/trans hemicaronic aldehyde derivatives, offering superior stereocontrol for pyrethroid manufacturing.
Patent CN112301064A reveals a biocatalytic route for high-purity DV acid. This method simplifies purification and ensures reliable agrochemical intermediate supply.
Patent CN1186310C details a tungsten-catalyzed oxidation route for agrochemical intermediates, offering safer processing and scalable production capabilities.
Patent CN1164557C reveals a halogen exchange method improving purity to 97% and yield to 91% for deltamethrin production. This advanced agrochemical intermediate process ensures stable supply chain continuity and substantial cost reduction for global buyers.
Novel side-arm ferrocene ligands enable efficient asymmetric cyclopropanation for pyrethroid production with high yield and selectivity.
Patent CN1373116A reveals a novel resolution method for agrochemical intermediates, offering significant cost reduction and supply chain reliability for pyrethroid manufacturers globally.
Advanced synthesis of 3,3-dimethylcyclopropane-1,2-dicarboxylic anhydride via safe oxidation. Reliable supplier for Hepatitis C drug intermediates with optimized cost and yield.
Novel ruthenium-catalyzed asymmetric cyclopropanation achieves high enantioselectivity trans-D-chrysanthemic acid with simplified process flow ensuring reliable supply chain efficiency for agrochemical manufacturers.
Solve low enantioselectivity in chrysanthemic acid production. Our ruthenium-catalyzed method achieves 90% ee with 97% hydrolysis yield. Reduce R&D costs.